Knoxville, TN, UNITED STATES, March 18, 2016– ABT Molecular Imaging has partnered with a world-renowned oncology group to install the BG-75 Biomarker Generator System in  The Republic of Cyprus.  The BG-75 integrates a compact cyclotron, micro-chemistry, and automated quality control, to provide on-demand F-18 FDG production in one seamless solution to support the implementation of PET/CT.

Radiology and biochemistry researchers at UC-San Diego say they have figured out how to dissolve and encapsulate metals inside fluorine-based droplets, in the process synthesizing a new cell-labeling probe that can, in in effect, “greatly amp up the MRI signal” for potential use in in immunotherapy, inflammation treatment and other emerging clinical applications. 

Want to know which specific hereditary ailments you, and you alone, are susceptible to? All of them? 

A new advancement in real-time visualization of body tissues using molecular imaging probes could significantly increase early detection and treatment capabilities of cancer and other diseases, according to results of a study published online in Nature Communications.

The FDA has issued a new draft guidance intended to assist FDA staff and those in the healthcare industry with submitting investigational device exemption (IDE) applications to conduct clinical trials for neurological medical devices. 

Of more than 1,500 tweets randomly pulled from a qualified starting cohort of more than 15,000 mentioning the term “lung cancer” over two and a half weeks in January 2015, just one lonely tweet linked to a patient recruitment website for a clinical trial.

Performing PET/CT examinations using the radiotracer 18-Fluoro-deoxyglucose (FDG) immediately following localized liver tumor ablation is more effective than contrast-enhanced CT for predicting tumor recurrence, according to results of a study published online in the Journal of Nuclear Medicine.

Patrick McDermott, a Rutgers University scientist who specializes in ionized radiation, has said a radiopharmaceutical factory scheduled to open soon in Millburn, N.J., poses no health risks to the area. McDermott was hired back in October 2015 to assess the safety of the factory and reported his findings this week.